SCINAI IMMUNOTHERAPEUTICS LTD. Operating Lease Right-of-Use Assets
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Operating Lease Right-of-Use Assets of $1.78 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-04-01
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.78M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $1.84M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $1.87M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $1.01M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $1.78M 20-F · filed 2026-04-01 |
| 2025-06-30 | $1.84M 6-K · filed 2025-09-02 |
| 2024-12-31 | $1.87M 20-F · filed 2026-04-01 |
| 2024-06-30 | $1.01M 6-K · filed 2024-09-09 |
| 2023-12-31 | $1.20M 20-F · filed 2025-05-07 |
| 2023-06-30 | $1.32M 6-K/A · filed 2023-08-18 |
| 2023-03-31 | $1.43M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.45M 20-F · filed 2024-05-15 |
| 2021-12-31 | $1.81M 10-K · filed 2023-04-17 |